🕵️ Ligand Pharmaceuticals Incorporated ($LGND)
SEC insider & ownership activity, last 12 months · CIK 886163 · every row links its SEC filing
Over the last 12 months insiders sold $35.0M with no open-market buying against it. Espinoza Octavio sold $13.0M through a 10b5-1 trading plan in 14 lots (Dec–Aug). BlackRock, Inc. trimmed 15.6% → 14.5%; Janus Henderson Group PLC trimmed 5.5% → 5.3%. No red-flag 8-Ks in the window.
🚨 3 signals active —
planned-vs-executed verdicts, pre-event flags, and cluster context live in the
API and the
alerts bot.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 9 sellers, $35.0M (132 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Espinoza Octavio | 0 | – | 14 | $13.0M | Aug 12, 2026 |
| Andrew Reardon | 0 | – | 54 | $8.8M | Sep 3, 2026 |
| Jason Haas | 0 | – | 3 | $3.7M | Aug 12, 2026 |
| Aryeh Jason | 0 | – | 5 | $3.0M | Jun 11, 2026 |
| John L. Lamattina | 0 | – | 7 | $2.4M | Jun 10, 2026 |
| Gray Nancy Ryan | 0 | – | 2 | $1.4M | Nov 7, 2025 |
| John W. Kozarich | 0 | – | 43 | $1.2M | May 13, 2026 |
| Stephen L. Sabba | 0 | – | 3 | $1.2M | Jun 16, 2026 |
| Zimmermann Martine | 0 | – | 1 | $342K | Sep 10, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14.5% | 13G | Oct 17, 2025 | filing ↗ | |
| Invesco Ltd. | 6.1% | 13G | Aug 13, 2026 | filing ↗ | |
| Vanguard Portfolio Management | 5.6% | 13G | May 1, 2026 | filing ↗ | |
| Janus Henderson Group PLC | 5.3% | 13G | Nov 14, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.0% | 13G | May 1, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Martine Zimmermann | $342K | Sep 10, 2026 | filing ↗ |
| Andrew Reardon | $4.3M | Sep 3, 2026 | filing ↗ |
| Octavio Espinoza | $9.1M | Aug 12, 2026 | filing ↗ |
| Jason Haas | $2.1M | Aug 12, 2026 | filing ↗ |
| Andrew Reardon | $3.2M | Jul 1, 2026 | filing ↗ |
| Stephen L. Sabba | $545K | Jun 16, 2026 | filing ↗ |
| Jason Haas | $1.7M | Jun 12, 2026 | filing ↗ |
| Aryeh Jason | $1.1M | Jun 11, 2026 | filing ↗ |
| Aryeh Jason | $125K | Jun 10, 2026 | filing ↗ |
| John L. Lamattina | $1.1M | Jun 10, 2026 | filing ↗ |
| Aryeh Jason | $1.2M | Jun 10, 2026 | filing ↗ |
| John Kozarich | $352K | May 13, 2026 | filing ↗ |
| John Kozarich | $103K | May 12, 2026 | filing ↗ |
| John W. Kozarich | $107K | May 1, 2026 | filing ↗ |
| John W. Kozarich | $95K | Apr 1, 2026 | filing ↗ |
| Stephen L. Sabba | $208K | Mar 23, 2026 | filing ↗ |
| Octavio Espinoza | $649K | Mar 11, 2026 | filing ↗ |
| John L. Lamattina | $434K | Mar 6, 2026 | filing ↗ |
| Andrew Reardon | $4.1M | Mar 4, 2026 | filing ↗ |
| Octavio Espinoza | $2.7M | Mar 4, 2026 | filing ↗ |
| Stephen L. Sabba | $410K | Mar 3, 2026 | filing ↗ |
| John W. Kozarich | $90K | Feb 2, 2026 | filing ↗ |
| John W. Kozarich | $88K | Jan 2, 2026 | filing ↗ |
| Octavio Espinoza | $340K | Dec 12, 2025 | filing ↗ |
| John W. Kozarich | $93K | Dec 1, 2025 | filing ↗ |
| Nancy Gray | $1.4M | Nov 7, 2025 | filing ↗ |
| John L. Lamattina | $859K | Nov 7, 2025 | filing ↗ |
| John W. Kozarich | $89K | Nov 3, 2025 | filing ↗ |
| John W. Kozarich | $83K | Oct 1, 2025 | filing ↗ |
| Jason M. Aryeh | $1.7M | Sep 23, 2025 | filing ↗ |
| Aryeh Jason | $1.7M | Sep 17, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Earnings (2.02) | Aug 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 6, 2026 | filing ↗ |
| Material agreement (1.01) | Jul 14, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jul 14, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 25, 2026 | filing ↗ |
| New financial obligation (2.03) | Jun 25, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 25, 2026 | filing ↗ |
| Other events (8.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 22, 2026 | filing ↗ |
| Other events (8.01) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 5, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 5, 2026 | filing ↗ |
| Material agreement (1.01) | May 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 16, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 27, 2026 | filing ↗ |
| Other events (8.01) | Apr 27, 2026 | filing ↗ |
| Agreement terminated (1.02) | Apr 24, 2026 | filing ↗ |
| Earnings (2.02) | Feb 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Dec 18, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |